Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study
出版年份 2021 全文链接
标题
Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study
作者
关键词
-
出版物
Aging Male
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2021-01-15
DOI
10.1080/13685538.2020.1867094
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease
- (2020) William E. Boden et al. AMERICAN HEART JOURNAL
- The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes
- (2018) Kristina Groti et al. Aging Male
- Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress
- (2018) Yue Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
- (2018) Kyung Mook Choi et al. Scientific Reports
- Type 2 Diabetes and Testosterone Therapy
- (2018) Geoffrey Hackett World Journal of Mens Health
- Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus
- (2018) L. Y. Morgunov et al. Aging Male
- MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial
- (2017) L V Magnussen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters
- (2016) Aksam Yassin et al. Aging Male
- Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study
- (2016) A. A. Yassin et al. ANDROLOGIA
- Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up
- (2016) Miyuki Yokoyama et al. DISEASE MARKERS
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury
- (2016) Arcangelo Barbonetti et al. JOURNAL OF SPINAL CORD MEDICINE
- Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study
- (2016) Christopher J D Wallis et al. Lancet Diabetes & Endocrinology
- Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports
- (2015) Farid Saad et al. Aging Male
- Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes
- (2015) Sandeep Dhindsa et al. DIABETES CARE
- Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies
- (2015) F Saad et al. INTERNATIONAL JOURNAL OF OBESITY
- Testosterone and obesity
- (2015) D. M. Kelly et al. Obesity Reviews
- Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus
- (2015) Bledar Daka et al. BMC Endocrine Disorders
- Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice
- (2014) Daniel M. Kelly et al. LIFE SCIENCES
- Loss of 5α-Reductase Type 1 Accelerates the Development of Hepatic Steatosis but Protects Against Hepatocellular Carcinoma in Male Mice
- (2013) Joanna K. Dowman et al. ENDOCRINOLOGY
- Testosterone Replacement Ameliorates Nonalcoholic Fatty Liver Disease in Castrated Male Rats
- (2013) L. Nikolaenko et al. ENDOCRINOLOGY
- Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
- (2013) A. M. Traish et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Testosterone: a metabolic hormone in health and disease
- (2013) Daniel M Kelly et al. JOURNAL OF ENDOCRINOLOGY
- Testosterone deficiency induces markedly decreased serum triglycerides, increased small dense LDL, and hepatic steatosis mediated by dysregulation of lipid assembly and secretion in mice fed a high-fat diet
- (2013) Takafumi Senmaru et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease
- (2012) Sunmi Kim et al. BMC GASTROENTEROLOGY
- Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial
- (2012) Camilla M Hoyos et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat
- (2012) Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
- (2011) T. H. Jones et al. DIABETES CARE
- Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
- (2011) C. Wang et al. DIABETES CARE
- Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
- (2010) Svetlana Y. Kalinchenko et al. CLINICAL ENDOCRINOLOGY
- Epidemiology of Non-Alcoholic Fatty Liver Disease
- (2010) Stefano Bellentani et al. DIGESTIVE DISEASES
- The relationship between testosterone and metabolic syndrome
- (2010) Hiroaki Kawano HYPERTENSION RESEARCH
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Testosterone deficiency: a risk factor for cardiovascular disease?
- (2010) T.H. Jones TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
- (2010) T. Hugh JONES Journal of Diabetes
- The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
- (2009) T. Hugh Jones et al. ATHEROSCLEROSIS
- Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men
- (2009) Henry Völzke et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease
- (2009) Alessandra Cornoldi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fifty-two-Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone
- (2009) A. E. Heufelder et al. JOURNAL OF ANDROLOGY
- Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
- (2008) Hung-Yun Lin et al. HEPATOLOGY
- The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
- (2008) A. M. Traish et al. JOURNAL OF ANDROLOGY
- The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
- (2008) Mariana Lazo et al. SEMINARS IN LIVER DISEASE
- Fatty Liver
- (2007) Anna Kotronen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search